AUM Pharmacy
Health Hub
Search Icon

AUM Pharmacy

Hi there!

Hello, Login
All Categories
VisaVisaVisa
fallback

Sitormin M 50mg/500mg Tablet SR

Prescription Icon
Prescription Required

Marketer

Xenon Pharmaceuticals

Salt Composition

Sitagliptin (50mg) + Metformin (500mg)

Overview Sitormin M 50mg/500mg Tablet SR

Combiflex DM 50mg/500mg extended-release tablets contain a dual-action formula to manage elevated blood glucose in individuals with type 2 diabetes. This helps mitigate severe diabetic complications like vision impairment and kidney disease, potentially lowering cardiovascular event risk. Combiflex DM may be used independently or in conjunction with other antidiabetic therapies. Optimal results are achieved with a balanced diet and regular physical activity. Dosage is personalized based on your health status, glucose readings, and concurrent medications. Ingesting it with food minimizes gastrointestinal discomfort. Consistent daily dosing at the same time maximizes effectiveness; discontinuation should only occur under physician guidance. Adherence to the prescribed diet and exercise plan is crucial. Lifestyle choices significantly impact diabetes control. Commonly reported side effects include nausea, vomiting, diarrhea, stomach upset, headache, and pharyngitis. Hypoglycemia is a potential adverse effect, particularly when combined with insulin or sulfonylureas; familiarity with its recognition and management is vital. This medication isn't universally suitable. Prior to commencing treatment, inform your doctor of any pre-existing kidney, liver, or heart conditions, pancreatic issues, or significant alcohol consumption. Pregnant or lactating individuals should seek medical counsel before use. Interactions with other medications are possible; disclose all medications to your doctor for safety assessment. Alcohol should be minimized due to its potential to decrease blood sugar. Your physician will monitor your renal function and blood glucose levels throughout treatment.

Primary Ingredients of Sitormin M 50mg/500mg Tablet SR

No information provided. Please provide the text you wish me to rephrase.

Uses of Sitormin M 50mg/500mg Tablet SR

Managing Type 2 Diabetes

Major Benefits of Sitormin M 50mg/500mg Tablet SR:

Follow your doctor's instructions precisely regarding dosage and treatment length for this medication. Ingest the Sitormin M 50mg/500mg Tablet SR whole; do not damage the tablet by chewing, crushing, or breaking it. Administer this medication with food.

Common Side effects of Sitormin M 50mg/500mg Tablet SR:

  • Decreased appetite
  • Vomiting
  • Upper respiratory tract infection
  • Hypoglycemia (low blood glucose level)
  • Abdominal bloating
  • Nausea
  • Diarrhea

How to use Sitormin M 50mg/500mg Tablet SR:

Follow your doctor's instructions precisely regarding dosage and treatment length for this medication. Ingest the Sitormin M 50mg/500mg Tablet SR whole; avoid chewing, crushing, or breaking it. Administer this medication with food.

How Sitormin M 50mg/500mg Tablet SR works:

Sitormin M 50mg/500mg sustained-release tablets combine sitagliptin and metformin to manage blood glucose levels. Sitagliptin enhances insulin production by the pancreas, improves insulin utilization, and decreases hepatic glucose output. Metformin, a biguanide, reduces liver glucose production, slows intestinal glucose absorption, and increases insulin sensitivity. This dual action achieves superior glycemic control.

SAFETY ADVICE

AlcoholAlcoholUNSAFE

Combining Sitormin M 50mg/500mg Tablet SR with alcohol is inadvisable.

PregnancyPregnancyCONSULT YOUR DOCTOR

The extended-release Sitormin M 50mg/500mg tablet may pose risks during pregnancy. While human data is scarce, animal research indicates potential harm to a developing fetus. A physician will assess the advantages against possible dangers prior to prescription. Seek medical advice.

Breast feedingBreast feedingCONSULT YOUR DOCTOR

Extended-release Sitormin M 50mg/500mg tablets may pose a risk to breastfeeding infants. Available human data indicates potential transfer to breast milk with the possibility of infant harm.

DrivingDrivingCAUTION

Driving may be impaired by excessively low or high blood glucose levels. Refrain from driving if such symptoms arise.

KidneyKidneyCAUTION

Patients with kidney impairment should use Sitormin M 50mg/500mg SR tablets cautiously, potentially requiring dosage modification. Consult your physician for guidance. Sitormin M 50mg/500mg SR tablets are contraindicated in patients with severe kidney disease. Regular kidney function monitoring is recommended during treatment.

LiverLiverUNSAFE

Patients with liver conditions should likely refrain from using Sitormin M 50mg/500mg SR tablets, as they may pose a safety risk. Medical advice is recommended.

What if you forget to take Sitormin M 50mg/500mg Tablet SR :

Should you forget to take a Sitormin M 50mg/500mg Tablet SR, administer it promptly. Nevertheless, if your next scheduled dose is imminent, omit the missed dose and resume your usual dosing regimen. Avoid taking a double dose.

Facts to Know About Sitormin M 50mg/500mg Tablet SR

LabelValue
Developing Habits No.
Treatment Category Diabetes Treatment

FAQs on Sitormin M 50mg/500mg Tablet SR

Sitormin M 50mg/500mg SR tablets combine sitagliptin and metformin to manage type 2 diabetes in adults. This combination improves blood sugar control when used with diet and exercise. Metformin reduces liver glucose production and enhances insulin sensitivity, while sitagliptin increases insulin release by inhibiting DPP-4. This medication is not suitable for individuals under 18.
Prolonged use of Sitormin M 50mg/500mg Tablet SR can lead to vitamin B12 deficiency by impairing its absorption. This deficiency, if left untreated, may result in anemia, neurological issues such as tingling, numbness in extremities, weakness, urinary difficulties, cognitive changes, and ataxia. To mitigate this risk, annual supplemental vitamin B12 is recommended by some researchers.
Sitormin M 50mg/500mg SR tablets may cause common side effects including hypoglycemia, altered taste, nausea, stomach pain, diarrhea, headache, and upper respiratory infections. Rare but serious side effects such as lactic acidosis are also possible. Prolonged use may result in vitamin B12 deficiency.
Patients with known allergies to Sitormin M 50mg/500mg Tablet SR components or excipients, or those with severe kidney or liver impairment, congestive heart failure, lactic acidosis, or diabetic ketoacidosis should not use this medication.
Combining Sitormin M 50mg/500mg SR tablets with alcohol is unsafe and may raise your risk of lactic acidosis.
Store this medication in its original, tightly closed container, following the storage instructions on the label. Discard any unused medication and keep it out of reach of children, pets, and others.
Sitormin M 50mg/500mg SR tablets can cause lactic acidosis (MALA – Metformin-associated lactic acidosis), a serious medical emergency resulting from excessive blood lactic acid. This rare side effect necessitates avoiding use in patients with kidney disease, the elderly, or those consuming significant alcohol. Symptoms include muscle pain/weakness, dizziness, fatigue, cold extremities, shortness of breath, nausea, vomiting, abdominal pain, and bradycardia. If experienced, discontinue Sitagliptin + Metformin immediately and seek medical attention.
Sitormin M 50mg/500mg SR tablets combine sitagliptin and metformin to manage type 2 diabetes in adults. This combination improves blood sugar control when used with diet and exercise. Metformin reduces liver glucose production and enhances insulin sensitivity, while sitagliptin boosts insulin release by inhibiting DPP-4. This medication is not suitable for individuals under 18.
Sitormin M 50mg/500mg SR tablets may cause common side effects such as hypoglycemia, taste changes, nausea, stomach pain, diarrhea, headache, and upper respiratory infections. Rare but serious side effects include lactic acidosis. Prolonged use can also result in vitamin B12 deficiency.
Patients with allergies to Sitormin M 50mg/500mg Tablet SR components or excipients, or those with severe kidney or liver impairment, congestive heart failure, lactic acidosis, or diabetic ketoacidosis should not use this medication.
Combining Sitormin M 50mg/500mg SR tablets with alcohol is unsafe and may heighten the risk of lactic acidosis.
Sitagliptin/Metformin (like Sitormin M 50mg/500mg SR) can cause lactic acidosis, a serious, potentially life-threatening buildup of lactic acid in the blood (also called MALA). This rare side effect is more likely in patients with kidney problems, older adults, or heavy alcohol users. Symptoms include muscle pain or weakness, dizziness, fatigue, cold extremities, shortness of breath, nausea, vomiting, abdominal pain, and slow heart rate. If you experience these, stop taking Sitagliptin/Metformin and seek immediate medical attention.
Prolonged use of Sitormin M 50mg/500mg SR tablets can lead to vitamin B12 deficiency by impairing its absorption. This deficiency, if left untreated, may cause anemia, neurological issues such as numbness and tingling in the extremities, weakness, urinary problems, cognitive changes, and balance difficulties (ataxia). To mitigate this risk, annual supplemental vitamin B12 is recommended by some researchers.
Store this medication in its original, tightly closed container, following the storage instructions on the label. Discard any unused medication and ensure it's inaccessible to children, pets, and others.
Sitormin M 50mg/500mg SR tablets combine sitagliptin and metformin to manage type 2 diabetes in adults. This combination improves blood sugar control when used with diet and exercise. Metformin reduces liver glucose production and enhances insulin sensitivity, while sitagliptin increases insulin release by inhibiting DPP-4. This medication is not suitable for individuals under 18.
Sitormin M 50mg/500mg SR Tablets may cause common side effects such as hypoglycemia, altered taste, nausea, stomach pain, diarrhea, headache, and upper respiratory infections. Rare but serious side effects include lactic acidosis. Prolonged use can also result in vitamin B12 deficiency.
Patients with known allergies to Sitormin M 50mg/500mg Tablet SR components or excipients, or those with severe kidney or liver impairment, congestive heart failure, lactic acidosis, or diabetic ketoacidosis, should not use this medication.
Combining Sitormin M 50mg/500mg SR tablets with alcohol is unsafe and may heighten the risk of lactic acidosis.
Sitagliptin/Metformin (like Sitormin M 50mg/500mg SR) can cause lactic acidosis, a serious medical emergency characterized by excessive blood lactic acid (also called Metformin-associated lactic acidosis or MALA). This rare side effect necessitates caution in patients with kidney disease, the elderly, or those who consume significant alcohol. Symptoms include muscle pain/weakness, dizziness, fatigue, cold extremities, shortness of breath, nausea, vomiting, abdominal pain, and bradycardia. If you experience these, discontinue Sitagliptin/Metformin and seek immediate medical attention.
Prolonged use of Sitormin M 50mg/500mg Tablet SR can lead to vitamin B12 deficiency by hindering its absorption in the stomach. This deficiency may cause anemia, nerve damage (manifesting as numbness, tingling in extremities, weakness, and balance problems), urinary issues, and cognitive changes. To mitigate these risks, supplemental vitamin B12 is recommended annually by some researchers.
Store this medication in its original, tightly closed container as directed on the label or packaging. Discard any unused medication and keep it out of reach of children, pets, and others.
Sitormin M 50mg/500mg Tab...
338